Evidence map›Paper›PMID 41753185›Full record

ArticleJournal of clinical medicine2026

Is Clinical Remission, an Ambitious Treatment Goal, Achievable in Patients with Moderate-to-Severe Asthma on Inhaled Therapies: How Ambitious Should We Be?

Soichiro Hozawa, Risako Ito, Jodie Crawford, Ryota Hibi, Alison Moore, Stephen G Noorduyn

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Soichiro HozawaHiroshima Allergy and Respiratory Clinic, Hiroshima 730-0013, Japan.ORCID 0000-0003-4572-7759
Risako ItoRespiratory/Immunology, Japan Real-World Evidence & Health Outcomes Research, GSK, Tokyo 107-0052, Japan.ORCID 0009-0006-6820-0561
Jodie CrawfordDevelopment Biostatistics, GSK, London WC1A 1DG, UK.
Ryota HibiRespiratory Medical Affairs, GSK, Tokyo 107-0052, Japan.
Alison MooreGlobal Medical Affairs, General Medicines, GSK, London WC1A 1DG, UK.
Stephen G NoorduynGlobal Real-World Evidence & Health Outcomes Research Organization, GSK, Mississauga, ON L5R 4H1, Canada.

Funding

GSK 207236/205715
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

asthmaAsthma Prevention and Management Guideline (JGL)clinical remissioninhaled therapiesJapanmoderate asthmapost hoc analysisPractical Guidelines for Asthma Management (PGAM)severe asthmasingle-inhaler triple therapy

Identifiers

PMID41753185
PMCPMC12941637

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.